Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!

The report “Biomarkers, Tests and Trends for Drug R&D” analyses the world market for biomarkers and tests used for drug R&D. The study reviews the market by examining biomarker related drug R&D spending, trends, major diseases, applications, M&As, alliances, tools and technologies, products and R&D services.

According to the 144 page report, major drug makers face competition from companies using key business and technical strategies that utilise biomarkers. Despite the recent severe recession, this business area is set for strong continued growth as biomarkers and tests in drug/therapeutic R&D enable emerging opportunities, potentially worth billions of dollars.

The study discusses ongoing government initiatives that foster worldwide development in biomarkers and personalised medicine opportunities. Their expectation is to streamline commercialsing new, safer, drugs and co-developed companion predictive tests by integrating biomarkers and pharmacogenomic (PGx) tests into the critical path of drug R&D. The study discusses how clinical trials are undergoing important emerging changes that integrate biomarkers and assays into the drug development process to provide more useful information in order for drug makers to make better product development decisions.

Report Buyer is the independent online store for global business information. The website now lists more than 120,000 company overviews, market research reports, industry studies and business books from over 300 specialist publishers. Thousands of professionals from across the world make ReportBuyer.com their first choice in their search for quality business insight.

Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Report Buyer Ltd securities in any jurisdiction including any other companies listed or named in this release.